drugset / Trial / NCT00983255
Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)
RandomizedFactorialQuadruple-blindBasic science
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of single rising and multiple rising IV doses of TR-701 FA and to determine the absolute bioavailability of oral TR-701 FA following single oral and IV dose administrations in healthy adult subjects.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tedizolid | Small molecule | 50 mg | Intravenous |
| Subject | Tedizolid | Small molecule | 100 mg | Intravenous |
| Subject | Tedizolid | Small molecule | 200 mg | Intravenous |
| Subject | Tedizolid | Small molecule | 300 mg | Intravenous |
| Subject | Tedizolid | Small molecule | 400 mg | Intravenous |